Skip to content

Clinical trials

Ocular Hypertension trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ocular Hypertension Country / region: United States Clear all

297 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20017
20024
20037
20041
20059
200614
200712
200814
200914
201013
201112
201216
201314
201425
201511
20166
20178
201815
201911
20209
202112
202210
20236
20249
202511
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed231
Recruiting22
Terminated14
Unknown status12
Withdrawn8
Active, not recruiting7
Not yet recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan41
Alcon Research32
Aerie Pharmaceuticals18
Santen Inc.12
Mati Therapeutics Inc.10
Bausch & Lomb Incorporated9
Glaukos Corporation8
Qlaris Bio, Inc.6
AbbVie5
ForSight Vision5, Inc.5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ocular Hypertension297
Glaucoma, Open-Angle187
Glaucoma152
Eye Diseases8
Hypertension8
Cataract7
Exfoliation Syndrome5
Diabetic Retinopathy4
Low Tension Glaucoma3
Macular Degeneration3

Trials

Showing 1 to 25 of 297. Each trial links to its page on Pharma Observatory.

197 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.